These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

704 related articles for article (PubMed ID: 23271318)

  • 1. A longitudinal follow-up of 550 mild cognitive impairment patients: evidence for large conversion to dementia rates and detection of major risk factors involved.
    Espinosa A; Alegret M; Valero S; Vinyes-Junqué G; Hernández I; Mauleón A; Rosende-Roca M; Ruiz A; López O; Tárraga L; Boada M
    J Alzheimers Dis; 2013; 34(3):769-80. PubMed ID: 23271318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Depressive Symptoms on Conversion from Mild Cognitive Impairment Subtypes to Alzheimer's Disease: A Community-Based Longitudinal Study.
    Kida J; Nemoto K; Ikejima C; Bun S; Kakuma T; Mizukami K; Asada T
    J Alzheimers Dis; 2016; 51(2):405-15. PubMed ID: 26890740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Between Olfactory Dysfunction and Amnestic Mild Cognitive Impairment and Alzheimer Disease Dementia.
    Roberts RO; Christianson TJ; Kremers WK; Mielke MM; Machulda MM; Vassilaki M; Alhurani RE; Geda YE; Knopman DS; Petersen RC
    JAMA Neurol; 2016 Jan; 73(1):93-101. PubMed ID: 26569387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conversion pattern and predictive factor of mild cognitive impairment in elderly Koreans.
    Shim SM; Song J; Kim JH; Jeon JP
    Arch Gerontol Geriatr; 2016; 64():146-50. PubMed ID: 26896864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk profiles of subtypes of mild cognitive impairment: the sydney memory and ageing study.
    Sachdev PS; Lipnicki DM; Crawford J; Reppermund S; Kochan NA; Trollor JN; Draper B; Slavin MJ; Kang K; Lux O; Mather KA; Brodaty H;
    J Am Geriatr Soc; 2012 Jan; 60(1):24-33. PubMed ID: 22142389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of mild cognitive impairment subtypes in patients attending a memory outpatient clinic--comparison of two modes of mild cognitive impairment classification. Results of the Vienna Conversion to Dementia Study.
    Pusswald G; Moser D; Gleiss A; Janzek-Hawlat S; Auff E; Dal-Bianco P; Lehrner J
    Alzheimers Dement; 2013 Jul; 9(4):366-76. PubMed ID: 23164551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conversion to dementia in mild cognitive impairment diagnosed with DSM-5 criteria and with Petersen's criteria.
    Marcos G; Santabárbara J; Lopez-Anton R; De-la-Cámara C; Gracia-García P; Lobo E; Pírez G; Menchón JM; Palomo T; Stephan BC; Brayne C; Lobo A;
    Acta Psychiatr Scand; 2016 May; 133(5):378-85. PubMed ID: 26685927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The validity of amnestic MCI and non-amnestic MCI at age 75 in the prediction of Alzheimer's dementia and vascular dementia.
    Jungwirth S; Zehetmayer S; Hinterberger M; Tragl KH; Fischer P
    Int Psychogeriatr; 2012 Jun; 24(6):959-66. PubMed ID: 22300486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive Composites Domain Scores Related to Neuroimaging Biomarkers within Probable-Amnestic Mild Cognitive Impairment-Storage Subtype.
    Espinosa A; Alegret M; Pesini P; Valero S; Lafuente A; Buendía M; San José I; Ibarria M; Tejero MA; Giménez J; Ruiz S; Hernández I; Pujadas F; Martínez-Lage P; Munuera J; Arbizu J; Tárraga L; Hendrix SB; Ruiz A; Becker JT; Landau SM; Sotolongo-Grau O; Sarasa M; Boada M; ;
    J Alzheimers Dis; 2017; 57(2):447-459. PubMed ID: 28269787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of Alzheimer disease in subjects with amnestic and nonamnestic MCI.
    Vos SJ; van Rossum IA; Verhey F; Knol DL; Soininen H; Wahlund LO; Hampel H; Tsolaki M; Minthon L; Frisoni GB; Froelich L; Nobili F; van der Flier W; Blennow K; Wolz R; Scheltens P; Visser PJ
    Neurology; 2013 Mar; 80(12):1124-32. PubMed ID: 23446677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of subtle amnestic and nonamnestic deficits in mild cognitive impairment: prognosis and conversion to dementia.
    Rountree SD; Waring SC; Chan WC; Lupo PJ; Darby EJ; Doody RS
    Dement Geriatr Cogn Disord; 2007; 24(6):476-82. PubMed ID: 17992015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Olfactory identification in amnestic and non-amnestic mild cognitive impairment and its neuropsychological correlates.
    Vyhnalek M; Magerova H; Andel R; Nikolai T; Kadlecova A; Laczo J; Hort J
    J Neurol Sci; 2015 Feb; 349(1-2):179-84. PubMed ID: 25614440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction Model of Conversion to Dementia Risk in Subjects with Amnestic Mild Cognitive Impairment: A Longitudinal, Multi-Center Clinic-Based Study.
    Jang H; Ye BS; Woo S; Kim SW; Chin J; Choi SH; Jeong JH; Yoon SJ; Yoon B; Park KW; Hong YJ; Kim HJ; Lockhart SN; Na DL; Seo SW
    J Alzheimers Dis; 2017; 60(4):1579-1587. PubMed ID: 28968237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-domain amnestic mild cognitive impairment identified by cluster analysis predicts Alzheimer's disease in the european prospective DESCRIPA study.
    Damian M; Hausner L; Jekel K; Richter M; Froelich L; Almkvist O; Boada M; Bullock R; De Deyn PP; Frisoni GB; Hampel H; Jones RW; Kehoe P; Lenoir H; Minthon L; Olde Rikkert MG; Rodriguez G; Scheltens P; Soininen H; Spiru L; Touchon J; Tsolaki M; Vellas B; Verhey FR; Winblad B; Wahlund LO; Wilcock G; Visser PJ
    Dement Geriatr Cogn Disord; 2013; 36(1-2):1-19. PubMed ID: 23651945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Memory performance on the story recall test and prediction of cognitive dysfunction progression in mild cognitive impairment and Alzheimer's dementia.
    Park JH; Park H; Sohn SW; Kim S; Park KW
    Geriatr Gerontol Int; 2017 Oct; 17(10):1603-1609. PubMed ID: 27910252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of white matter lesions and cognitive deficits on conversion from mild cognitive impairment to Alzheimer's disease.
    Defrancesco M; Marksteiner J; Deisenhammer E; Kemmler G; Djurdjevic T; Schocke M
    J Alzheimers Dis; 2013; 34(3):665-72. PubMed ID: 23254639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical relevance of amnestic versus non-amnestic mild cognitive impairment subtyping in Parkinson's disease.
    Chung SJ; Park YH; Yun HJ; Kwon H; Yoo HS; Sohn YH; Lee JM; Lee PH
    Eur J Neurol; 2019 May; 26(5):766-773. PubMed ID: 30565368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mild cognitive impairment in a community sample: the Sydney Memory and Ageing Study.
    Brodaty H; Heffernan M; Kochan NA; Draper B; Trollor JN; Reppermund S; Slavin MJ; Sachdev PS
    Alzheimers Dement; 2013 May; 9(3):310-317.e1. PubMed ID: 23110866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Framingham Risk Score and the Risk of Progression from Mild Cognitive Impairment to Dementia.
    Viticchi G; Falsetti L; Buratti L; Sajeva G; Luzzi S; Bartolini M; Provinciali L; Silvestrini M
    J Alzheimers Dis; 2017; 59(1):67-75. PubMed ID: 28582863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring Genetic Associations of Alzheimer's Disease Loci With Mild Cognitive Impairment Neurocognitive Endophenotypes.
    Espinosa A; Hernández-Olasagarre B; Moreno-Grau S; Kleineidam L; Heilmann-Heimbach S; Hernández I; Wolfsgruber S; Wagner H; Rosende-Roca M; Mauleón A; Vargas L; Lafuente A; Rodríguez-Gómez O; Abdelnour C; Gil S; Marquié M; Santos-Santos MA; Sanabria Á; Ortega G; Monté-Rubio G; Pérez A; Ibarria M; Ruiz S; Kornhuber J; Peters O; Frölich L; Hüll M; Wiltfang J; Luck T; Riedel-Heller S; Montrreal L; Cañabate P; Moreno M; Preckler S; Aguilera N; de Rojas I; Orellana A; Alegret M; Valero S; Nöthen MM; Wagner M; Jessen F; Tárraga L; Boada M; Ramírez A; Ruiz A
    Front Aging Neurosci; 2018; 10():340. PubMed ID: 30425636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.